Novavax (NVAX) EV to CFO (2020 - 2024)
Novavax's (NVAX) EV to CFO came in at 68.26 for Q2 2024.
Powered by 
Analysis
Novavax (NVAX) EV to CFO (2020 - 2024) Analysis & Trends
For the trailing twelve months through Jun 30, 2024, EV to CFO at Novavax was -50.82; for FY2021, it was 28.91.
- The Q2 2024 figure stands as the highest quarterly EV to CFO since Q3 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn |
| 10 | Novavax | 1.80 Bn | -1.06 Bn | 44.81 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | 68.26 |
| Dec 31, 2021 | 28.91 |
| Sep 30, 2021 | 25.52 |
| Jun 30, 2021 | 20.36 |
| Mar 31, 2021 | 17.76 |
| Sep 30, 2020 | 101.38 |
| Jun 30, 2020 | 125.94 |
API Access
Novavax EV to CFO API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=NVAX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-cfo", "ticker": "NVAX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=NVAX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();